EDGAR Filing Documents for 0001104659-20-048247

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001104659-20-048247

Filing Date

2020-04-17

Accepted

2020-04-17 16:56:10

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	tm2016274d1_424b3.htm	424B3	528063
2	GRAPHIC	tm2013443d1_f3sp1-img001.jpg	GRAPHIC	14892
3	GRAPHIC	tm2013443d1_f3sp1-img002.jpg	GRAPHIC	13402
	Complete submission text file	0001104659-20-048247.txt		568530

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 424B3 | Act: 33 | File No.: 333-237389 | Film No.: 20800333
SIC: 2834 Pharmaceutical Preparations